News
40m
Dealbreaker on MSNEli Lilly Pays $1 Billion For Non-Opioid Pain Med MakerEli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results